Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bally

Showing results (201-210 of 225) with videos related to

Pageof 23
Sort By:
Biochimica Et Biophysica Acta|April 3, 2007
Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein bindingNancy Dos Santos, Christine Allen, Anne-Marie Doppen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2014
Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancerSuganthi Chittaranjan, Svetlana Bortnik, Wieslawa H Dragowska, et al.
Oncotarget|August 25, 2016
Identification of breast cancer cell subtypes sensitive to ATG4B inhibitionSvetlana Bortnik, Courtney Choutka, Hugo M Horlings, et al.
Cancer Research|January 7, 2006
Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survivalArmelle A Troussard, Paul C McDonald, Elizabeth D Wederell, et al.
Cancer Research|June 16, 2011
A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiationVictor W Ho, Kelvin Leung, Anderson Hsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2017
<i>In Vivo</i> Validation of PAPSS1 (3'-phosphoadenosine 5'-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic TargetAda W Y Leung, Chansey J Veinotte, Nicole Melong, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 2, 2021
Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug DeliveryRoy van der Meel, Sam Chen, Josh Zaifman, et al.
Molecular Cancer Research : MCR|November 25, 2004
HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularizationWieslawa H Dragowska, Corinna Warburton, Donald T T Yapp, et al.
Plos One|March 4, 2016
Combined Use of Gene Expression Modeling and siRNA Screening Identifies Genes and Pathways Which Enhance the Activity of Cisplatin When Added at No Effect Levels to Non-Small Cell Lung Cancer Cells In VitroAda W Y Leung, Stacy S Hung, Ian Backstrom, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 6, 2010
Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticlesIgor V Zhigaltsev, Geoff Winters, Masuna Srinivasulu, et al.
Pageof 23

Showing results (201-210 of 225) with videos related to

Sort By:
Pageof 23
Biochimica Et Biophysica Acta|April 3, 2007
Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein bindingNancy Dos Santos, Christine Allen, Anne-Marie Doppen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2014
Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancerSuganthi Chittaranjan, Svetlana Bortnik, Wieslawa H Dragowska, et al.
Oncotarget|August 25, 2016
Identification of breast cancer cell subtypes sensitive to ATG4B inhibitionSvetlana Bortnik, Courtney Choutka, Hugo M Horlings, et al.
Cancer Research|January 7, 2006
Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survivalArmelle A Troussard, Paul C McDonald, Elizabeth D Wederell, et al.
Cancer Research|June 16, 2011
A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiationVictor W Ho, Kelvin Leung, Anderson Hsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2017
<i>In Vivo</i> Validation of PAPSS1 (3'-phosphoadenosine 5'-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic TargetAda W Y Leung, Chansey J Veinotte, Nicole Melong, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 2, 2021
Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug DeliveryRoy van der Meel, Sam Chen, Josh Zaifman, et al.
Molecular Cancer Research : MCR|November 25, 2004
HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularizationWieslawa H Dragowska, Corinna Warburton, Donald T T Yapp, et al.
Plos One|March 4, 2016
Combined Use of Gene Expression Modeling and siRNA Screening Identifies Genes and Pathways Which Enhance the Activity of Cisplatin When Added at No Effect Levels to Non-Small Cell Lung Cancer Cells In VitroAda W Y Leung, Stacy S Hung, Ian Backstrom, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 6, 2010
Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticlesIgor V Zhigaltsev, Geoff Winters, Masuna Srinivasulu, et al.
Pageof 23